ATRS - Antares Pharma, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
798.18M
Enterprise Value 3
790.48M
Trailing P/E
N/A
Forward P/E 1
32.60
PEG Ratio (5 yr expected) 1
-1.53
Price/Sales (ttm)
7.61
Price/Book (mrq)
17.98
Enterprise Value/Revenue 3
7.54
Enterprise Value/EBITDA 6
-106.03

Trading Information

Stock Price History

Beta (3Y Monthly) 0.93
52-Week Change 351.57%
S&P500 52-Week Change 318.19%
52 Week High 35.1300
52 Week Low 32.5300
50-Day Moving Average 34.0700
200-Day Moving Average 33.4127

Share Statistics

Avg Vol (3 month) 31.61M
Avg Vol (10 day) 31.81M
Shares Outstanding 5163.23M
Float 150.58M
% Held by Insiders 17.34%
% Held by Institutions 142.29%
Shares Short (Nov 15, 2019) 43.39M
Short Ratio (Nov 15, 2019) 41.71
Short % of Float (Nov 15, 2019) 42.11%
Short % of Shares Outstanding (Nov 15, 2019) 42.07%
Shares Short (prior month Oct 15, 2019) 44.49M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 25/1
Last Split Date 3Jan 29, 1999

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin -0.56%
Operating Margin (ttm)-9.81%

Management Effectiveness

Return on Assets (ttm)-6.51%
Return on Equity (ttm)-1.71%

Income Statement

Revenue (ttm)104.85M
Revenue Per Share (ttm)0.65
Quarterly Revenue Growth (yoy)92.00%
Gross Profit (ttm)32.49M
EBITDA -7.46M
Net Income Avi to Common (ttm)-588k
Diluted EPS (ttm)-0.0040
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)41.87M
Total Cash Per Share (mrq)0.26
Total Debt (mrq)45.61M
Total Debt/Equity (mrq)102.68
Current Ratio (mrq)2.95
Book Value Per Share (mrq)0.27

Cash Flow Statement

Operating Cash Flow (ttm)-16.65M
Levered Free Cash Flow (ttm)-22.56M